Healthcare - Biotechnology - NASDAQ - GB
$ 11.2
-3.78 %
$ 8.15 B
Market Cap
1.95
P/E
BALANCE SHEET
7.22 B
ASSETS
774 M
LIABILITIES
5.97 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Roivant Sciences Ltd.
| Current Assets | 6.73 B |
| Cash & Short-Term Investments | 6.54 B |
| Receivables | 82.8 M |
| Other Current Assets | 108 M |
| Non-Current Assets | 491 M |
| Long-Term Investments | 248 M |
| PP&E | 66 M |
| Other Non-Current Assets | 177 M |
| Current Liabilities | 267 M |
| Accounts Payable | 53.2 M |
| Short-Term Debt | 21.9 M |
| Other Current Liabilities | 192 M |
| Non-Current Liabilities | 507 M |
| Long-Term Debt | 478 M |
| Other Non-Current Liabilities | 29.3 M |
Balance Sheet
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 6 535.7 | 1 676.8 | 2 060.4 | 2 055.0 | 2 185.5 |
| Short Term Investments | 5.4 | 5.0 | 0 | 77.7 | 0 |
| Receivables | 82.8 | 37.6 | 6.7 | 13.8 | 15.3 |
| Inventory | 35.3 | 2.8 | 0 | 0 | 1 |
| Other Current Assets | 72.7 | 81.3 | 79.4 | 40.4 | 18.5 |
| Total Current Assets | 6 731.8 | 1 798.6 | 2 146.5 | 2 187.0 | 2 219.2 |
| PP&E | 66.0 | 92.3 | 86.9 | 77.0 | 73.9 |
| Intangible Assets | 137.8 | 144.9 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 247.8 | 304.3 | 325.8 | 289.5 | 177.2 |
| Other Long Term Assets | 39.1 | 49.5 | 25.8 | 36.1 | 6.7 |
| Other Assets | 0 | 0 | 0 | 100.0 | 0 |
| Total Assets | 7 222.5 | 2 389.6 | 2 585.1 | 2 689.7 | 2 477.1 |
| LIABILITIES | |||||
| Accounts Payable | 53.2 | 37.8 | 34.6 | 20.6 | 10.3 |
| Short Term Debt | 21.9 | 52.4 | 11.4 | 12.3 | 7.8 |
| Other Current Liabilities | 177.0 | 169.2 | 127.5 | 180.2 | 69.9 |
| Total Current Liabilities | 266.8 | 272.4 | 184.4 | 219.0 | 92.1 |
| Long Term Debt | 477.9 | 429.0 | 272.5 | 232.7 | 173.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 29.3 | 80.6 | 53.1 | 76.1 | 103.2 |
| Total Liabilities | 774.0 | 782.0 | 523.7 | 527.7 | 368.4 |
| EQUITY | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 576.2 | (3 772.8) | (2 763.7) | (1 918.5) | (1 109.2) |
| Other Accumulative Comprehensive Income/Loss | (4.1) | (2.6) | (0.9) | 1.4 | (2.3) |
| Total Equity | 6 448.5 | 1 607.6 | 2 061.4 | 2 062.0 | 2 108.7 |
| Total Liabilities and Equity | 7 222.5 | 2 389.6 | 2 585.1 | 2 589.7 | 2 477.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 783.2 | 712.8 | 669.8 | 684.8 | 215.4 |